ODI Pharma AB (publ) (NGM:ODI)
Sweden
· Delayed Price · Currency is SEK 1.600
+0.120 (8.11%)
At close: Dec 4, 2025
ODI Pharma AB Income Statement
Financials in millions SEK. Fiscal year is July - June.
Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2019 |
| Revenue | 8.96 | 3.13 | 22.29 | 0.14 | 0.31 | - | Upgrade
|
| Revenue Growth (YoY) | -59.10% | -85.94% | 15880.34% | -55.44% | - | - | Upgrade
|
| Cost of Revenue | 6.77 | 2.29 | 17.66 | 0.86 | 0.42 | - | Upgrade
|
| Gross Profit | 2.19 | 0.84 | 4.62 | -0.72 | -0.1 | - | Upgrade
|
| Selling, General & Admin | 5.78 | 6.11 | 6.54 | 6.09 | 7.12 | 3.92 | Upgrade
|
| Other Operating Expenses | 0.41 | 0.18 | -2.35 | -0 | -0.02 | 0.04 | Upgrade
|
| Operating Expenses | 6.19 | 6.29 | 4.19 | 6.09 | 7.1 | 3.96 | Upgrade
|
| Operating Income | -4 | -5.45 | 0.43 | -6.81 | -7.21 | -3.96 | Upgrade
|
| Interest Expense | -0.73 | -0.74 | -0.86 | -0.11 | -0.03 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.24 | 0.26 | 0.05 | 0.02 | 0 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | - | - | - | - | Upgrade
|
| Pretax Income | -4.5 | -5.93 | -0.38 | -6.9 | -7.24 | -3.97 | Upgrade
|
| Income Tax Expense | 0 | 0 | 0.19 | 0.01 | 0 | 0.01 | Upgrade
|
| Net Income | -4.5 | -5.93 | -0.57 | -6.9 | -7.24 | -3.98 | Upgrade
|
| Net Income to Common | -4.5 | -5.93 | -0.57 | -6.9 | -7.24 | -3.98 | Upgrade
|
| Shares Outstanding (Basic) | 19 | 19 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 19 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 26.93% | 21.82% | -0.76% | 1.69% | -1.52% | 11.10% | Upgrade
|
| EPS (Basic) | -0.23 | -0.32 | -0.04 | -0.45 | -0.48 | -0.26 | Upgrade
|
| EPS (Diluted) | -0.23 | -0.32 | -0.04 | -0.45 | -0.48 | -0.26 | Upgrade
|
| Free Cash Flow | -3.92 | -3.31 | -3.82 | -5.1 | -7.38 | -6.06 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.18 | -0.25 | -0.33 | -0.49 | -0.40 | Upgrade
|
| Gross Margin | 24.48% | 26.77% | 20.74% | - | -33.12% | - | Upgrade
|
| Operating Margin | -44.64% | -173.94% | 1.92% | -4884.20% | -2302.98% | - | Upgrade
|
| Profit Margin | -50.26% | -189.33% | -2.55% | -4948.58% | -2313.25% | - | Upgrade
|
| Free Cash Flow Margin | -43.80% | -105.49% | -17.16% | -3659.83% | -2357.80% | - | Upgrade
|
| EBITDA | -4 | -5.45 | 0.43 | -6.81 | -7.2 | -3.96 | Upgrade
|
| EBITDA Margin | -44.62% | -173.88% | 1.93% | - | - | - | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
| EBIT | -4 | -5.45 | 0.43 | -6.81 | -7.21 | -3.96 | Upgrade
|
| EBIT Margin | -44.64% | -173.94% | 1.92% | - | - | - | Upgrade
|
| Revenue as Reported | 9.2 | 3.45 | 25.33 | 0.18 | 0.4 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.